Schneider Ryan M. 4

What Happened

• Ryan M. Schneider, a member of Elevance Health's Board of Directors, received a grant of 563 deferred stock units on 2026-05-13. The units were issued at $0.00 (award), so the reported acquisition value is $0.
• These are deferred stock units (not immediate common shares). They represent a future right to receive company common stock under the Board of Directors Compensation Program rather than a cash purchase or sale.

Key Details

• Transaction date: 2026-05-13; Form filed: 2026-05-15 (timely filing).
• Transaction code: A (award/grant); Shares/units granted: 563; Reported price: $0.00; Reported value: $0.
• Shares owned after transaction: Not specified in the provided Form 4.
• Footnotes: F1—units accrued under the Company’s Board of Directors Compensation Program. F2—units payable in company common stock upon the earlier of (a) five years from grant or (b) the date the director leaves the board, unless a later date was elected under the Deferred Compensation Plan.
• Filing timeliness: Filed two days after the grant date (within standard insider-reporting window), so not late.

Context

• Deferred stock units are a form of compensation that convert to shares at a future date and do not represent an immediate open-market purchase or sale. Grants like this are common for non-employee directors and are routine compensation, not direct indicators of near-term trading intent.